Simon’s Blog
Search⌘ K
← Back to the bookshelf

Topic 03 / Investment research

2026 A-Shares: 72 Companies with ROIC above 20%

73 articles · 10/13/2026 updated

2026 A-Share ROIC above 20%: A 72-Company Research Project

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 1: Tongzhou Electronics — Avoid the ROIC Trap

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 2: Chongqing Brewery — Relatively Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 3: Eoptolink — Fully Priced In

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 4: Zhongyida — A Company to Avoid

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 5: Wancheng Group — Cautious Observation

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 6: Sanrui Intelligent — A Newly Listed Company

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 7: TFC Communication — Waiting for Validation

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 8: Innolight — A Market Favorite

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 9: Sunshine Guojian — Waiting for Catalysts

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 10: G-bits — Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 11: TCL Smart Home — Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 12: Acter — Cautious Avoidance

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 13: Eastroc Beverage — Waiting for a Second Growth Engine

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 14: Yutong Bus — Relatively Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 15: Allist — Fairly Valued to Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 16: Hithink RoyalFlush — Fairly Valued to Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 17: Ice River Network — Significantly Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 18: Tebao Biological — Fairly Valued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 19: Shengda Forestry — A Company to Avoid

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 20: Shanxi Fenjiu — Still Waiting

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 21: Kweichow Moutai — Undervalued, but Patience Is Needed

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 22: Supor — Years of Decline

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 24: Yealink — Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 23: Action Education — A Limited Growth Ceiling

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 25: Bluetrum — Waiting and Watching

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 26: HeartCare Medical — Already Priced In

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 27: Darentang — Waiting for an Entry Opportunity

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 28: Lakala — Limited Upside

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 29: Yanjin Shop — Waiting for the Right Moment

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 30: Higold Group — Neutral Hold

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 31: Hongqiao Holdings — Worth Considering

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 34: Zangge Mining — Considering Pullbacks

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 32: Neway Valve — Relatively Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 33: Sanmei — A Poor Time to Chase

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 35: Deye — Steady Hold

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 36: Sungrow — Steady Hold

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 37: Guanghe Technology — Already Priced In

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 38: Rockchip — Worth Considering

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 39: Sichuan Gold — Overvalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 40: Victory Giant Technology — Already Priced In

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 41: WuXi AppTec — A Cash Machine Awaiting Recovery

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 42: Sinofuse — Overvalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 43: Gongniu Group — Awaiting Recovery

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 44: Meyer Optoelectronic — A Mature Cash Cow

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 45: Ninebot — Already Priced In

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 46: Gude Electrical Materials — Already Priced In

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 47: Proya — Waiting for a Turnaround

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 48: Guocheng Mining — Tied Closely to Molybdenum Prices

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 49: Zhengdan — Near a Low Point

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 50: Kingnet Network — Fairly Valued to Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 51: Chifeng Gold — Worth Waiting For

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 52: Fostar — Strongly Favored

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 53: Sieyuan Electric — Neutral Hold

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 54: Lingrui Pharmaceutical — Cautious Hold

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 55: Changchuan Technology — Fairly Valued to Expensive

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 56: Dahao Technology — Fairly Valued to Undervalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 57: Anker Innovations — Long-Term Hold

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 58: Himile — Considering Pullbacks

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 59: Shenma Power — Waiting for a Pullback

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 60: Sinexcel — Overvalued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 61: UGREEN — Fairly Valued to Expensive

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 62: Wus Printed Circuit — Already Priced In

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 63: Farad Electronics — Expensive

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 64: Sund Industrial — Fairly Valued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 65: Rich Intelligent — A Newly Listed Company

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 66: Hisense Home Appliances — Holding and Waiting

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 67: Tubao — Waiting for Recovery

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 68: Jinbei Automotive — Dependent on BMW

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 69: J.S. Machine — Waiting for Recovery

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 70: Yunnan Aluminium — Fairly Valued to Expensive

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 71: CFMOTO — Fairly Valued

English version awaiting publication. You can read the original article in Chinese.

Read article
ROIC Study 72: CCGrass — Fairly Valued to Expensive

English version awaiting publication. You can read the original article in Chinese.

Read article